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Background and purpose — Integration of repaired cartilage 
with surrounding native cartilage is a major challenge for suc-
cessful tissue-engineering strategies of cartilage repair. We inves-
tigated whether incorporation of mesenchymal stem cells (MSCs) 
into the collagen scaffold improves integration and repair of car-
tilage defects in a cynomolgus macaque model. 
Methods — Cynomolgus macaque bone marrow-derived 
MSCs were isolated and incorporated into type-I collagen gel. 
Full-thickness osteochondral defects (3 mm in diameter, 5 mm 
in depth) were created in the patellar groove of 36 knees of 18 
macaques and were either left untreated (null group, n = 12), had 
collagen gel alone inserted (gel group, n = 12), or had collagen gel 
incorporating MSCs inserted (MSC group, n = 12). After 6, 12, 
and 24 weeks, the cartilage integration and tissue response were 
evaluated macroscopically and histologically (4 null, 4 gel, and 4 
MSC knees at each time point). 
Results — The gel group showed most cartilage-rich reparative 
tissue covering the defect, owing to formation of excessive carti-
lage extruding though the insufficient subchondral bone. Despite 
the fact that a lower amount of new cartilage was produced, the 
MSC group had better-quality cartilage with regular surface, 
seamless integration with neighboring naïve cartilage, and recon-
struction of trabecular subchondral bone.
Interpretation — Even with intensive investigation, MSC-based 
cell therapy has not yet been established in experimental cartilage 
repair. Our model using cynomolgus macaques had optimized 
conditions, and the method using MSCs is superior to other 
experimental settings, allowing the possibility that the procedure 
might be introduced to future clinical practice. 

Articular cartilage has a limited capacity for repair, leading to 
further degeneration without treatment of a defect. A number 
of surgical options, including microfracture (Redman et al. 
2004), osteochondral grafting (Matsusue et al. 1993, Gross 
et al. 2008), and cell-based techniques such as autologous 
chondrocyte implantation (ACI) (Brittberg et al. 1994) have 
been developed and are used in clinical settings. However, 
cartilage injuries treated with microfracturing may deteriorate 
with time as a result of the high proportion of fibrocartilage 
(Mithoefer et al. 2009), or a lack of lateral integration between 
host and donor cartilage may remain after osteochondral graft-
ing (Lane et al. 2004).
With the chondrocyte implantation procedure, the chondro-
cytes are harvested from the joint and then expanded in vitro. 
In this process, the cells may dedifferentiate and attenuate 
their ability to produce collagen type II, the major collagen 
component of normal hyaline cartilage (Grigolo et al. 2002). 
One concern in using first-generation ACI was a re-arthros-
copy rate of 20–25% during the first 1–2 years (Henderson et 
al. 2006, Knutsen et al. 2004) where hypertrophy of the repair 
tissue has been found in most cases. 
As an alternative treatment, tissue engineering has been 
demonstrated to be a promising approach to restoring cartilage 
defects. Mesenchymal stem cells (MSCs) are multipotent pro-
genitor cells that may differentiate into several cell lineages 
including chondrocytes. MSCs have theoretical advantages 
over chondrocytes regarding potential for healing. Such cells 
have the ability to proliferate without losing their ability to dif-
ferentiate into mature chondrocytes producing collagen II and 
aggrecan. In the short term, bone marrow-derived MSCs com-
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bined with scaffolds have been successful in cartilage repair 
using animal models such as rabbits (Dashtdar et al. 2011), 
sheep (Zscharnack et al. 2010), and horses (Wilke et al. 2007).
In this study, we tested the hypothesis that expanded bone 
marrow-derived MSCs in a collagen scaffold would improve 
healing of osteochondral injury in a novel animal model using 
cynomolgus macaques. Since there have been no previous 
studies using MSCs of primates for cartilage repair, we con-
firmed pluripotency of the MSCs by differentiation assay after 
isolation. We then studied in vivo responses to MSC trans-
plantation using a cartilage injury model in the cynomolgus 
macaque. Cell and tissue responses to the MSC transplanta-
tion were evaluated by macroscopic and histological examina-
tion at 6, 12, and 24 weeks.
material and methods
Animal care
18 skeletally mature cynomolgus macaques (approximately 
5–7 years old, weighing 7–9 kg) were used. The animals were 
allowed to move freely in their cages immediately after sur-
gery, and most animals were immediately able to bear weight 
on both legs. The experiment was performed according to 
the guidelines for animal research at the Shiga University of 
Medical Science.
Bone marrow fluid
Bone marrow was harvested under anesthesia induced by intra-
muscular injection of Ketalar (5 mg/kg). A 4-cm skin incision 
was made over the anterior aspect of the upper arm under ster-
ile conditions. 2 needles were inserted into the humerus with 
one end of the extension tube connected to a syringe containing 
20 mL phosphate-buffered saline (PBS) with 10 U/mL heparin. 
The other end of the extension tube was connected to an empty 
syringe. The PBS was pushed gently from the syringe into the 
bone marrow cavity to flush out the bone marrow fluid. The 
medium containing the bone marrow fluid was collected into 
the syringe, and the process was repeated twice.
Isolation and expansion of MSCs
Harvested bone marrow cells were filtered through a 70-μm 
nylon filter (Becton, Franklin Lakes, NJ) with remaining tis-
sues discarded. The cells were plated at 5 × 104 cells/cm2 in 
αMEM containing 10% fetal bovine serum (FBS) (Invitrogen, 
Eugene, OR), 100 units/mL penicillin, 100 μg/mL streptomy-
cin, and 250 ng/mL amphotericin B, and incubated at 37ºC 
in a humidified atmosphere of 5% CO2. After 3–4 days, the 
medium was changed to remove the non-adherent cells and 
the adherent cells were cultured for another 14 days (passage 
0). Then the cells were trypsinized, harvested, and re-seeded 
at 50 cells/cm2. After 14 additional days of culture, the cells 
were harvested as passage 1. In order to confirm that the 
MSCs had colony-forming properties, 100 cells were plated in 
60-cm2 dishes, cultured for 14 days, and stained with Giemsa.
In vitro differentiation assay
100 bone marrow cells at passage 1 were cultured for another 
14 days. Then pluripotency of the MSCs was confirmed by 
differentiation assay. For adipogenesis or osteogenesis, the 
medium was changed either to adipogenic medium (MK429; 
Adipo-Inducer Reagent, Takara, Otsu Japan) or to osteogenic 
medium (MK430, Osteoblast-Inducer Reagent, Takara). 
The cells were cultured for 14 days, with the medium being 
changed twice a week. The adipogenesis differentiation was 
confirmed by staining with oil red O solution. The osteogen-
esis differentiation was confirmed by alkaline phosphatase 
staining (ALP).
For chondrogenesis, the medium was changed to chondro-
genetic base medium (CCM005, human/mouse StemXVivo 
Chondrogenetic Base Media; R&D Systems, Minneapolis, 
MN) with supplement (CCM006 human/mouse StemXVivo 
Chondrogenetic Supplement, R&D Systems). The cells were 
cultured for up to 14 days with a medium change twice a 
week. Collected cell pellets were fixed, embedded in paraffin, 
cut into 5-μm sections, and stained with hematoxylin-eosin 
(HE) or stained immunohistochemically for type-II collagens.
Biomaterial and preparation of implants 
Passage 1 cells were suspended at 1 × 106 cells/mL in αMEM. 
After incubation for 20 min at 37ºC in 5% CO2, the cells 
were centrifuged at 450 g for 5 min and washed twice with 
PBS. They were then mixed with an equal volume of colla-
gen gel (Aterocollagen, 3% type-I collagen; Koken, Tokyo, 
Japan). The collagen gel-cell mixture was placed in a 6-well 
plate with 3 mL αMEM and 20% FBS added to the culture for 
hardening of the gel.
Creation and repair of the osteochondral defects 
4 weeks after harvest of bone marrow, the macaques were 
operated in both knees under sterile conditions and under anes-
thesia induced by intramuscular injection of Ketalar (5 mg/
kg). Through a medial parapatellar incision, a 3-mm diameter 
and 5-mm deep defect was created over the patellar groove 
using a stainless-steel punch. Osteochondral defects were cre-
ated in the patellar groove of 36 knees of 18 macaques. The 
cartilage defects were either implanted with collagen gel or 
left untreated. The experimental group implanted with col-
lagen gel containing MSCs was designated the MSC group 
(n = 12), while the experimental group implanted with colla-
gen gel without MSCs was designated the gel group (n = 12). 
The experimental group not implanted with collagen gel but 
left untreated served as a negative control, and was designated 
the null group (n = 12). The animals were killed at scheduled 
time points; i.e. after 6, 12, and 24 weeks (corresponding to 
4 null, 4 gel, and 4 MSC knees at each time point (Table 1)). 
Cartilage integration and tissue response were evaluated mac-
roscopically and histologically.
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Postoperative condition and welfare of the animals
After the surgery, the animals were returned to their cages 
without cast immobilization (macaques bite cast until it breaks 
off). However, cynomolgus macaques do not normally run 
about in the standard cage, but sit on a perch set up in the 
cage. We did not see any great difference in the postoperative 
behavior between animals that were given different implants. 
They were killed with an overdose of sodium pentobarbital, 
and the knees were evaluated by histological examination at 6, 
12, and 24 weeks after surgery.
Histological examination
The dissected knees were fixed in 4% paraformaldehyde, 
decalcified in 4% EDTA solution, and embedded in paraffin 
blocks. 5-μm thickness sections were obtained from the center 
of each defect and stained with toluidine blue. Randomly 
chosen histological sections were examined under the light 
microscope for histomorphometrical analysis using Image-Pro 
Plus (IPP) 6.0 software (Media Cybernetics Inc, Acton, MA). 
According to the area of positive toluidine blue staining, the 
percentage of new cartilage tissue area in the cartilage defect 
area was calculated following the instructions of the software 
provider (Media Cybernetics). We used the filter function to 
remove false- positives. The percentage of new cartilage tissue 
area was calculated as follows: % new cartilage area = (area 
of new cartilage) / (area of estimated cartilage layer) × 100.
For overall evaluation of the regenerated tissue in the defect 
area, the repaired tissues were graded blind by 3 observers 
using Caplan’s histological grading scale (Caplan et al. 1997). 
In this grading scale, the repair tissue is evaluated in 6 cat-
egories, i.e. cell morphology, reconstruction of subchondral 
bone, matrix staining, filling of defect, surface regularity, and 
bonding of graft edge. A total of 16 points stands for normal 
articular cartilage and 0 represents no regeneration.
results
Characteristics of bone marrow-derived MSCs 
Cells isolated from the bone marrow of cynomolgus macaques 
using the present protocol showed a distinct colony-forming 
property that was compatible with the characteristics of 
MSCs. It has been long known that isolated MSCs have col-
ony-forming potential (Friedenstein 1976).
To confirm that the cells isolated represented a group of 
MSCs, their differentiation potentials were confirmed by dif-
ferentiation assay. Adipogenic colonies were stained with oil 
red O, whereas osteogenetic colonies were stained with ALP 
stain. For chondrogenetic potential, pellets of the cells were 
stained for type-II collagen by immunostaining (Figure 1).
Macroscopic observation (Figure 2)
We did not observe any severe synovitis, osteophyte forma-
tion, or infection in any of the animals. The full-thickness car-
tilage defects of the null group, which were untreated (without 
inserting collagen gel), remained uncovered at the different 
time points of the study (6, 12, and 24 weeks postoperatively). 
In the cartilage defects of the gel group, sharp edges of the 
defects were visible at 6 weeks. At 12 weeks, the defects were 
thinly covered with reparative tissue, with the reddish color 
of the marrow becoming vague. At 24 weeks, the defect was 
covered with thick reparative tissue, though the central region 
of the defects often remained uncovered, with a hollow-like 
deformity (arrow in Figure 2). 
In the MSC group, the sharp edges of the defects were vis-
ible at 6 weeks postoperatively. At 12 weeks, the defects were 
evenly covered with yellowish reparative tissue. At 24 weeks, 
the defects were covered with watery hyaline cartilage-like 
tissue similar to the neighboring naïve cartilage. 
Histological observation by toluidine blue staining 
(Figures 3 and 4)
The repair process of each experimental group was first evalu-
Table 1. Distribution of implant patterns
Implant pattern 6-week model 12-week model 24-week model
(right – left) 2 animals 2 animals 2 animals
  4 knees 4 knees 4 knees
Null a – Gel Null – Gel Null – Gel Null – Gel
(6 animals/12 knees) Null – Gel Null – Gel Null – Gel
Gel b – MSC c Gel – MSC Gel – MSC Gel – MSC
(6 animals/12 knees) Gel – MSC Gel – MSC Gel – MSC
Null – MSC Null – MSC Null – MSC Null – MSC
(6 animals/12 knees) Null – MSC Null – MSC Null – MSC
Total number of each
experimantal design
 Null / Gel / MSC 4 / 4 / 4 4 / 4 / 4 4 / 4 / 4
a  Null: Osteochondral defects without implants.
b Gel: Osteochondral defects implanted with gel alone.
c MSC: Osteochondral defects implanted with gel incorporated with MSC
Immunohistochemical examination for type-I 
and type-II collagen
The expression of type-I and -II collagens in the repar-
ative tissue was studied immunohistochemically. We 
used a mouse monoclonal antibody to human type-I 
and -II collagens that has been verified to cross-react 
with primate type-I and -II collagens. For the immuno-
histochemical examination, the sections were stained 
as previously described (Mimura et al. 2008).
Statistics
Results are expressed as median values and interquartile 
range (IQR). Kruskal-Wallis test was used to determine 
significant differences among groups. Any p-value of 
less than 0.05 was considered to be significant.
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ated by toluidine blue staining. In the full-thickness 
defect of the null group, the subchondral region was 
filled with amorphous reparative tissue at 6 weeks 
postoperatively, with the cartilage layer uncovered. 
At 12 weeks, the reparative tissue in the subchon-
dral region was faintly stained with toluidine blue, 
reflecting involvement of endochondral ossification. 
At 24 weeks, bone tissue reappeared in the subchon-
dral bone region, although it did not consist of tra-
becular structure with marrow space but of woven 
bone-like structure.
In the gel group, the reparative tissue in the sub-
chondral region involved some toluidine blue-posi-
tive cartilaginous tissue at 6 weeks. At 12 weeks, the 
faintly stained layer covered the defect. At 24 weeks, 
the defect was covered with the cartilaginous layer, 
although the central region was often faintly stained 
by toluidine blue. The reconstruction of subchondral 
bone was often insufficient—lacking any supportive 
structure for the cartilage layer, and there was exces-
sive growth of cartilage into the subchondral region.
In the MSC group, the trabecular structure of sub-
chondral bone had already reappeared. At 12 weeks, 
the tidemark structure that discriminates between the 
articular cartilage and subchondral bone had reap-
peared. At 24 weeks, the thickness of the toluidine 
blue-stained cartilage layer was comparable to that 
of the neighboring naïve cartilage.
Comparison of all 24-week toluidine blue histol-
ogy sections confirmed that the gel group showed 
most cartilage-rich reparative tissue covering the 
defect, owing to formation of excessive cartilage 
extruding though the insufficient subchondral bone. 
Despite the lower amount of new cartilage produced, 
the MSC group showed better-quality cartilage with 
a regular surface, seamless integration with neigh-
boring naïve cartilage, and reconstruction of trabecu-
lar subchondral bone.
Quantitative evaluation
Quantitative histological evaluation showed a statis-
tically significantly higher degree of new cartilage 
area in the gel and MSC groups at 12 and 24 weeks 
postoperatively compared to the null group (Table 2). 
However, there was no significant difference between 
the gel group and the MSC group.
Qualitative histological evaluation for type-I 
and type-II collagen (Figure 5)
In the null group, the reparative tissue covering the 
cartilage defect was intensely positive for type-I col-
lagen at 24 weeks. The corresponding region was 
typically negative for type-II collagen, suggesting 
that the repair tissue had scar-like properties.
Figure 1. Characteristics of bone marrow-derived MSCs. Panel (a) demonstrates 
the colony-forming properties of MSCs isolated from bone marrow of cynomolgus 
macaques using the present protocol (arrows). Bar: 1 cm. Panel (b) shows the 
adipogenetic properties of MSC-derived cells from staining of lipid droplets with 
oil red O (arrowheads). Bar: 20 μm. Panel (c) confirms the osteoblastic properties 
of MSC-derived cells with alkaline phosphatase staining (arrowheads). Bar: 30 
μm. Panel (d) confirms the chondrogenetic properties from immunostaining of 
type-II collagen. Type-II collagen-positive matrix is stained red. Bar: 0.5 mm.
Figure 2. Macroscopic observations of the repaired defects in the 3 groups at 6 
weeks (a, d, g), 12 weeks (b, e, h), and 24 weeks (c, f, i) after implantation. Scale 
bar: 5 mm. Arrow in (d): the sharp edge of the defect is visible at 6 weeks in the 
gel group. Arrow in (f): a hollow-like deformity remains in the central region of the 
defect, despite thick coverage by the reparative tissue. Arrow in (g): the sharp 
edge of the defect is also visible in the MSC group at 6 weeks. 
weeks Null gel mSC
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In the gel group, the repair tissue was negative for 
type-I collagen but positive for type-II collagen, sug-
gesting cartilage-like properties. In accordance with 
the histological findings from toluidine blue staining, 
the subchondral bone had no trabecular structure.
In the MSC group, the thickness of the type-I nega-
tive and type-II positive layer was consistent with that 
of the neighboring naïve cartilage. In addition, the 
type-I positive subchondral bone had a clear outline 
of the tidemark beneath the regenerated cartilage.
Qualitative histological evaluation by histo-
logical scaling (Figure 6)
Morphological characteristics of the regenerated 
cartilage-like tissue were evaluated using Caplan’s 
histological grading scale (Caplan et al. 1997). The 
MSC group had the highest points of all the experi-
mental groups for all the time points studied. The 
qualitative histological scores of the MSC group 
were significantly higher than those of the other 2 
groups at 24 weeks (p < 0.05).
Discussion
The ultimate outcome of cartilage repair depends 
on seamless integration between the host cartilage 
and the repair cartilage. MSC-based cell therapy 
is expected to be a viable alternative for cartilage 
repair. Bone marrow-derived MSCs combined with 
scaffolds have been successful in animal models 
weeks Null gel mSC
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12
24
Figure 3. Histological findings after toluidine blue staining in the 3 groups at 6 
weeks (a, d, g), 12 weeks (b, e, h), and 24 weeks (c, f, i) after implantation. Scale 
bar: 2 mm. Dotted line in (a): amorphous reparative tissue filling the subchondral 
region. Arrowheads in (b): faint toluidine blue staining that reflects involvement 
of endochondral ossification. Arrowhead in (c): toluidine blue-negative reparative 
tissue covering the defect. Dotted line in (c): reconstructed subchondral bone 
consisting of woven bone-like structure. Arrowhead in (d): toluidine blue-positive 
cartilaginous tissue. Arrowhead in (e): thin faintly toluidine blue-positive layer cov-
ering the defect. Arrowhead in (f): the unstained central region of the cartilaginous 
layer covering the defect. Arrow in (f): excessive cartilage extruding through the 
deficient tidemark. Dotted line in (g): woven bone-like subchondral bone already 
re-appearing at 6 weeks. Arrowhead in (h): reconstructed tidemark distinctly dis-
criminating the articular cartilage from the subchondral bone.
Figure 4. Comparison of all 
24-week toluidine blue histology 
sections. Histological findings 
after toluidine blue staining of 
the gel group (a, b, c, d), the null 
group (e, f, g, h), and the MSC 
group (i, j, k, l). Scale bar: 3 mm.
gel
Null  
mSC
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such as rabbits (Dashtdar et al. 2011), sheep (Zscharnack et 
al. 2010), and horses (Wilke et al. 2007). In the present study, 
we characterized the repair process of MSC-based cell therapy 
using another animal model, the cynomolgus macaque. 
We defined MSCs as being cells derived from bone marrow 
cells with the functional capacity for self-renewal and to gen-
erate a number of differentiated progeny (Mckay 1997). Since 
the pioneering work by Friedenstein (1976), the colony-form-
ing-unit fibroblast assay has been one of the standard assays 
for identification of MSCs, with isolation of the adherent, 
spindle-shaped cells that proliferate to form distinct colonies. 
By this method, we first isolated colony-forming cells from 
primate bone marrow cells. We then confirmed their multipo-
tency in vitro by the differentiation assay.
We found that the gel group had regeneration with more car-
tilaginous tissue, less fibrous tissue, and higher histological 
scores than the null group at both 12 weeks and 24 weeks. Our 
previous studies have shown that the endogenous stem cells 
arising from the bone marrow can be captured and organized 
by collagen gel and can participate in cartilage repair (Kubo et 
al. 2007, Mimura et al. 2008, Nishizawa et al. 2010). However, 
the number of stem cells that are derived from the local bone 
marrow is limited. Thus, we believe that the MSC-loaded col-
lagen scaffolds resulted in improved cartilage repair, provid-
ing larger numbers of stem cells.
Some authors reported a larger percentage of new cartilage 
area with MSCs than without MSCs (Guo et al. 2004, Uematsu 
et al. 2005). However, we did not find such an improvement 
in the MSC group over the gel group. The higher percentage 
of new cartilage area in the gel group is likely to have been 
due to the excessive cartilage protruding into the marrow 
space. The protruding cartilage was not of the best quality, 
however, being partly positive for type-I collagen. Thus, our 
findings support previous findings showing no differences in 
the percentage of new cartilage area—i.e. amount of neocarti-
lage produced—compared to that without MSCs in a different 
model (Radice et al. 2000). However, the repaired tissue in the 
MSC group was macroscopically much smoother and of better 
quality histologically than in the gel group. 
It should be noted that the result of qualitative evaluation 
of the regenerated cartilage in the MSC group was superior to 
that in the gel group. The superior quality of the regenerated 
cartilage in the MSC group was also shown by the absence 
of type-I collagen and the abundance of type-II collagen. 
Moreover, complete reconstruction of the tidemark on the 
Collagen Null gel mSC
  I
II
Figure 5. Histological findings after immunohistochemistry for type-I collagen (a, 
b, c) and type-II collagen (b, d, f) in the 3 groups 24 weeks after implantation. 
Scale bar: 2 mm. Immunopositive staining is brown, and immunonegative matrix 
is stained purple. Arrowhead in (a): intensely collagen type-I positive repair tissue 
covering the defect. Arrowhead in (b): collagen type-II-void reparative tissue cov-
ering the defect. Arrowhead in (c): very faint collagen type-I positivity in the repair 
tissue. Arrow in (c, d): excessive cartilage extruding through the deficient tide-
mark. Arrowhead in (d): partly positive collagen type-II immunoreactivity in the 
repair tissue. Arrowheads in (e, f): formation of distinct tidemark discriminating the 
articular cartilage and subchondral bone consisting of lamellar bone.
Table 2. Percentage of new cartilage area in the experimental 
groups. Values are median (interquartile range)
  Null group Gel Group MSC group p-value a
12 weeks 5 (3–7)   38 (45–44) 39 (36–46) 0.02 b
24 weeks 2 (2–4) 124 (118–130) 99 (94–104) 0.007 b
Percentage of new cartilage tissue area was calculated as (area of 
new cartilage) / (area of estimated cartilage layer) x 100.
a  Kruskal–Wallis test.
b Significant difference between Null group and Gel, MSC groups 
  (p < 0.05)
Figure 6. Qualitative histological evaluation by Caplan’s 
histological grading scale. The qualitative histological 
scores of the MSC group were significantly higher than 
those of the other 2 groups at 24 weeks (p < 0.05). There 
were no significant inter-observer differences in this his-
tological grading.
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subchondral bone and seamless integration with the native 
cartilage should be noted, despite the lower amount of neo-
cartilage.
A previous study investigating the application of osteogenic 
MSCs associated with scaffold has also shown that they result 
in better quality of regenerated cartilage and better quality of 
subchondral bone (Nakamura et al. 2010). Thus, transplanted 
MSCs are likely to contribute to the regeneration of subchon-
dral bone, although the present study did not address this 
issue. Another study is needed to prove the participation of 
the MSC-derived osteogenic cells in subchondral bone for-
mation, perhaps by labeling of the MSCs for viability. In the 
present study, the MSC group had superior surfaces, thick-
ness, and quality of the regenerated cartilage as well as better 
integration of the repair cartilage and the subchondral bone, 
i.e. tidemark formation. The repair tissues in the null group 
and gel group were inadequately integrated with the subchon-
dral bone. This indicates that proper regeneration of subchon-
dral bone may contribute to the regeneration of cartilage, and 
delayed bone formation may have resulted in a lack of appro-
priate mechanical support for the development of overlying 
cartilage. These results may give some hints on repairing bone 
and cartilage defects. The mechanism by which subchondral 
bone integration is regulated is unclear. An understanding of 
this mechanism is important because we know that in the long 
term, if integration with subchondral bone does not occur, the 
regenerated cartilage may well deteriorate and fail.
We chose to use cynomolgus macaques because the healing 
potential may depend on the animal species. A high degree of 
spontaneous healing is known to occur with defects of up to 3 
mm diameter in a rabbit model, with less spontaneous healing 
in larger defects (Shapiro et al. 1993). In the present study, 
spontaneous repair did not take place in the 3-mm defects of 
the null group. Our preliminary study had demonstrated that 
spontaneous repair occurred only with defects up to 2 mm 
in diameter (data not shown). Although the rabbit is widely 
studied in experimental cartilage repair and it has also been 
used previously by our group (Kubo et al. 2007, Mimura et al. 
2008, Nishizawa et al. 2010), the healing potential of different 
animal species, particularly of primates, is of great interest. 
To obtain a sufficiently long observation time and to keep the 
number of cynomolgus macaques needed to a reasonable level 
with enough statistical power, we chose 24 weeks as a suitable 
time point.
The present study had several limitations. Firstly, we used 
type-I collagen produced in porcine dermis (Aterocollagen 
(3% type-I collagen); Koken, Tokyo, Japan). This collagen has 
been approved for a long time for clinical use and its reliabil-
ity has been established due to the absence of any antigenicity. 
We prepared autologous MSCs for the present study, while 
some of the earlier studies have used allogenic MSCs for the 
sake of easy handling (Løken et al. 2008). In the clinical set-
ting, however, allogenic MSCs cannot be used—in order to 
avoid unnecessary graft-versus-host reactions. 
We seeded MSCs on the scaffold 12 h before implantation. 
The provider of Aterocollagen® (Koken) recommended that 
the collagen gel should be kept in culture medium overnight 
after mixing with reaction buffer, in order to obtain suf-
ficient hardness—for the sake of handling. In other experi-
mental studies using MSCs in scaffolds, the time from seed-
ing to implantation, when stated, has often been less than 
48 h (Redman et al. 2004, Labbe et al. 2011). One reason 
for choosing a relatively short time interval from seeding to 
implantation is that differentiation of MSCs into chondro-
cytes is probably facilitated by local factors in the joint and 
cartilage. Thus, the time interval of 12 h in the present proto-
col was appropriate.
Another limitation stems from the use of dependent data. 
Each animal contributed 2 observations, i.e. MSCs vs gel, 
MSCs vs null, or gel vs null, which were treated as inde-
pendent observations in the statistical analysis. Theoreti-
cally speaking, each animal should have contributed to only 
1 experimental observation, but the number of animals was 
limited for the sake of animal welfare according to the animal 
research guidelines of our institute. Thus, we must accept that 
the p-values that we calculated in the present study were prob-
ably inordinately low due to our use of dependent data.
Despite these limitations, we believe that the present study 
provides valuable information on the influence of MSCs on 
cartilage regeneration, particularly when using the cynomol-
gus macaque. The combination of the transplantation of auto-
logous MSCs in collagen gel and traditional strategies gave 
regeneration of better-quality cartilage with a regular surface, 
seamless integration with neighboring native cartilage. Also it 
gave reconstruction of trabecular subchondral bone and tide-
mark which supports the regenerated cartilage. 
However, the percentage of new cartilage area was not 
improved by adding MSCs to the scaffold (Table 2). Since 
spontaneous healing probably accounts for the absence of 
improvement in the percentage of new cartilage area in the 
MSC group relative to the gel group, another study design 
using larger defects, e.g. 5 mm in diameter, might result in 
a more clear-cut difference in the degree of new cartilage 
between the MSC group and the gel group. Application in 
larger defects is certainly in line with future clinical use. If 
MSCs—under optimized conditions—turn out to be superior 
to chondrocyte implantation in experimental cartilage repair, 
the procedure should be introduced to clinical practice after 
well-controlled randomized clinical trials.
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